nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—PLK1—uterine cervix—fallopian tube cancer	0.0179	0.0179	CbGeAlD
Ruxolitinib—PLK1—uterus—fallopian tube cancer	0.0149	0.0149	CbGeAlD
Ruxolitinib—CAMK1—uterine cervix—fallopian tube cancer	0.014	0.014	CbGeAlD
Ruxolitinib—PRKCE—female reproductive system—fallopian tube cancer	0.014	0.014	CbGeAlD
Ruxolitinib—PLK3—endometrium—fallopian tube cancer	0.0135	0.0135	CbGeAlD
Ruxolitinib—RPS6KA6—female reproductive system—fallopian tube cancer	0.0134	0.0134	CbGeAlD
Ruxolitinib—PLK1—female reproductive system—fallopian tube cancer	0.0134	0.0134	CbGeAlD
Ruxolitinib—CAMK1—endometrium—fallopian tube cancer	0.0126	0.0126	CbGeAlD
Ruxolitinib—JAK1—epithelium—fallopian tube cancer	0.0116	0.0116	CbGeAlD
Ruxolitinib—DCLK3—vagina—fallopian tube cancer	0.0115	0.0115	CbGeAlD
Ruxolitinib—JAK1—uterine cervix—fallopian tube cancer	0.0115	0.0115	CbGeAlD
Ruxolitinib—DCLK1—uterine cervix—fallopian tube cancer	0.0115	0.0115	CbGeAlD
Ruxolitinib—PLK3—female reproductive system—fallopian tube cancer	0.0112	0.0112	CbGeAlD
Ruxolitinib—DAPK2—uterine cervix—fallopian tube cancer	0.0109	0.0109	CbGeAlD
Ruxolitinib—LTK—female reproductive system—fallopian tube cancer	0.0108	0.0108	CbGeAlD
Ruxolitinib—CAMK1—female reproductive system—fallopian tube cancer	0.0105	0.0105	CbGeAlD
Ruxolitinib—JAK1—endometrium—fallopian tube cancer	0.0104	0.0104	CbGeAlD
Ruxolitinib—PLK3—female gonad—fallopian tube cancer	0.0102	0.0102	CbGeAlD
Ruxolitinib—CLK2—uterine cervix—fallopian tube cancer	0.0102	0.0102	CbGeAlD
Ruxolitinib—MARK2—female reproductive system—fallopian tube cancer	0.0102	0.0102	CbGeAlD
Ruxolitinib—PLK3—vagina—fallopian tube cancer	0.0101	0.0101	CbGeAlD
Ruxolitinib—ROCK1—epithelium—fallopian tube cancer	0.00996	0.00996	CbGeAlD
Ruxolitinib—DAPK2—endometrium—fallopian tube cancer	0.00989	0.00989	CbGeAlD
Ruxolitinib—JAK1—uterus—fallopian tube cancer	0.00956	0.00956	CbGeAlD
Ruxolitinib—DCLK1—uterus—fallopian tube cancer	0.00956	0.00956	CbGeAlD
Ruxolitinib—CAMK1—female gonad—fallopian tube cancer	0.00953	0.00953	CbGeAlD
Ruxolitinib—CAMK1—vagina—fallopian tube cancer	0.00947	0.00947	CbGeAlD
Ruxolitinib—DAPK3—endometrium—fallopian tube cancer	0.0093	0.0093	CbGeAlD
Ruxolitinib—CLK2—endometrium—fallopian tube cancer	0.00921	0.00921	CbGeAlD
Ruxolitinib—NUAK2—uterine cervix—fallopian tube cancer	0.00917	0.00917	CbGeAlD
Ruxolitinib—JAK3—female reproductive system—fallopian tube cancer	0.00864	0.00864	CbGeAlD
Ruxolitinib—JAK1—female reproductive system—fallopian tube cancer	0.00859	0.00859	CbGeAlD
Ruxolitinib—CAMK2G—uterine cervix—fallopian tube cancer	0.00858	0.00858	CbGeAlD
Ruxolitinib—BMP2K—uterine cervix—fallopian tube cancer	0.00858	0.00858	CbGeAlD
Ruxolitinib—DAPK3—uterus—fallopian tube cancer	0.00857	0.00857	CbGeAlD
Ruxolitinib—TAOK2—female gonad—fallopian tube cancer	0.00856	0.00856	CbGeAlD
Ruxolitinib—PLK4—female reproductive system—fallopian tube cancer	0.00854	0.00854	CbGeAlD
Ruxolitinib—TAOK2—vagina—fallopian tube cancer	0.00851	0.00851	CbGeAlD
Ruxolitinib—LRRK2—uterine cervix—fallopian tube cancer	0.00851	0.00851	CbGeAlD
Ruxolitinib—PHKG2—female reproductive system—fallopian tube cancer	0.00834	0.00834	CbGeAlD
Ruxolitinib—NUAK2—endometrium—fallopian tube cancer	0.00829	0.00829	CbGeAlD
Ruxolitinib—STK16—female reproductive system—fallopian tube cancer	0.00806	0.00806	CbGeAlD
Ruxolitinib—HIPK2—female reproductive system—fallopian tube cancer	0.00802	0.00802	CbGeAlD
Ruxolitinib—BMPR2—uterus—fallopian tube cancer	0.00799	0.00799	CbGeAlD
Ruxolitinib—JAK3—female gonad—fallopian tube cancer	0.00787	0.00787	CbGeAlD
Ruxolitinib—MAP3K19—female reproductive system—fallopian tube cancer	0.00786	0.00786	CbGeAlD
Ruxolitinib—JAK1—female gonad—fallopian tube cancer	0.00782	0.00782	CbGeAlD
Ruxolitinib—MAP3K2—uterine cervix—fallopian tube cancer	0.00779	0.00779	CbGeAlD
Ruxolitinib—JAK1—vagina—fallopian tube cancer	0.00777	0.00777	CbGeAlD
Ruxolitinib—DCLK1—vagina—fallopian tube cancer	0.00777	0.00777	CbGeAlD
Ruxolitinib—CAMK2G—endometrium—fallopian tube cancer	0.00776	0.00776	CbGeAlD
Ruxolitinib—BMP2K—endometrium—fallopian tube cancer	0.00776	0.00776	CbGeAlD
Ruxolitinib—MAP3K7—uterine cervix—fallopian tube cancer	0.00772	0.00772	CbGeAlD
Ruxolitinib—DAPK3—female reproductive system—fallopian tube cancer	0.00771	0.00771	CbGeAlD
Ruxolitinib—LRRK2—endometrium—fallopian tube cancer	0.00769	0.00769	CbGeAlD
Ruxolitinib—CLK2—female reproductive system—fallopian tube cancer	0.00763	0.00763	CbGeAlD
Ruxolitinib—CAMK1D—female gonad—fallopian tube cancer	0.00763	0.00763	CbGeAlD
Ruxolitinib—PHKG2—female gonad—fallopian tube cancer	0.00758	0.00758	CbGeAlD
Ruxolitinib—CAMK1D—vagina—fallopian tube cancer	0.00758	0.00758	CbGeAlD
Ruxolitinib—TYK2—uterine cervix—fallopian tube cancer	0.00758	0.00758	CbGeAlD
Ruxolitinib—MKNK2—epithelium—fallopian tube cancer	0.00755	0.00755	CbGeAlD
Ruxolitinib—MKNK2—uterine cervix—fallopian tube cancer	0.00748	0.00748	CbGeAlD
Ruxolitinib—IRAK1—uterine cervix—fallopian tube cancer	0.00748	0.00748	CbGeAlD
Ruxolitinib—DAPK2—female gonad—fallopian tube cancer	0.00746	0.00746	CbGeAlD
Ruxolitinib—DAPK2—vagina—fallopian tube cancer	0.00741	0.00741	CbGeAlD
Ruxolitinib—ROCK1—female reproductive system—fallopian tube cancer	0.0074	0.0074	CbGeAlD
Ruxolitinib—RET—epithelium—fallopian tube cancer	0.00736	0.00736	CbGeAlD
Ruxolitinib—STK16—female gonad—fallopian tube cancer	0.00734	0.00734	CbGeAlD
Ruxolitinib—HIPK2—female gonad—fallopian tube cancer	0.0073	0.0073	CbGeAlD
Ruxolitinib—STK16—vagina—fallopian tube cancer	0.00729	0.00729	CbGeAlD
Ruxolitinib—DYRK1A—female reproductive system—fallopian tube cancer	0.00721	0.00721	CbGeAlD
Ruxolitinib—BMPR2—female reproductive system—fallopian tube cancer	0.00719	0.00719	CbGeAlD
Ruxolitinib—CAMK2G—uterus—fallopian tube cancer	0.00715	0.00715	CbGeAlD
Ruxolitinib—DAPK3—female gonad—fallopian tube cancer	0.00701	0.00701	CbGeAlD
Ruxolitinib—MAP3K7—endometrium—fallopian tube cancer	0.00698	0.00698	CbGeAlD
Ruxolitinib—DAPK3—vagina—fallopian tube cancer	0.00697	0.00697	CbGeAlD
Ruxolitinib—JAK2—epithelium—fallopian tube cancer	0.00696	0.00696	CbGeAlD
Ruxolitinib—CLK2—female gonad—fallopian tube cancer	0.00695	0.00695	CbGeAlD
Ruxolitinib—CLK2—vagina—fallopian tube cancer	0.0069	0.0069	CbGeAlD
Ruxolitinib—JAK2—uterine cervix—fallopian tube cancer	0.0069	0.0069	CbGeAlD
Ruxolitinib—TYK2—endometrium—fallopian tube cancer	0.00686	0.00686	CbGeAlD
Ruxolitinib—MKNK2—endometrium—fallopian tube cancer	0.00677	0.00677	CbGeAlD
Ruxolitinib—ROCK1—female gonad—fallopian tube cancer	0.00673	0.00673	CbGeAlD
Ruxolitinib—MAP3K3—uterine cervix—fallopian tube cancer	0.00665	0.00665	CbGeAlD
Ruxolitinib—DYRK1A—female gonad—fallopian tube cancer	0.00657	0.00657	CbGeAlD
Ruxolitinib—BMPR2—female gonad—fallopian tube cancer	0.00654	0.00654	CbGeAlD
Ruxolitinib—BMPR2—vagina—fallopian tube cancer	0.0065	0.0065	CbGeAlD
Ruxolitinib—MAP3K2—uterus—fallopian tube cancer	0.0065	0.0065	CbGeAlD
Ruxolitinib—MAP3K7—uterus—fallopian tube cancer	0.00643	0.00643	CbGeAlD
Ruxolitinib—BMP2K—female reproductive system—fallopian tube cancer	0.00643	0.00643	CbGeAlD
Ruxolitinib—CAMK2G—female reproductive system—fallopian tube cancer	0.00643	0.00643	CbGeAlD
Ruxolitinib—LRRK2—female reproductive system—fallopian tube cancer	0.00637	0.00637	CbGeAlD
Ruxolitinib—TYK2—uterus—fallopian tube cancer	0.00632	0.00632	CbGeAlD
Ruxolitinib—NUAK2—female gonad—fallopian tube cancer	0.00625	0.00625	CbGeAlD
Ruxolitinib—JAK2—endometrium—fallopian tube cancer	0.00624	0.00624	CbGeAlD
Ruxolitinib—MKNK2—uterus—fallopian tube cancer	0.00624	0.00624	CbGeAlD
Ruxolitinib—NUAK2—vagina—fallopian tube cancer	0.00621	0.00621	CbGeAlD
Ruxolitinib—TAOK3—uterine cervix—fallopian tube cancer	0.00606	0.00606	CbGeAlD
Ruxolitinib—MAP3K3—endometrium—fallopian tube cancer	0.00601	0.00601	CbGeAlD
Ruxolitinib—CAMK2G—female gonad—fallopian tube cancer	0.00585	0.00585	CbGeAlD
Ruxolitinib—BMP2K—female gonad—fallopian tube cancer	0.00585	0.00585	CbGeAlD
Ruxolitinib—MAP3K2—female reproductive system—fallopian tube cancer	0.00584	0.00584	CbGeAlD
Ruxolitinib—BMP2K—vagina—fallopian tube cancer	0.00582	0.00582	CbGeAlD
Ruxolitinib—CAMK2G—vagina—fallopian tube cancer	0.00582	0.00582	CbGeAlD
Ruxolitinib—LRRK2—female gonad—fallopian tube cancer	0.0058	0.0058	CbGeAlD
Ruxolitinib—LRRK2—vagina—fallopian tube cancer	0.00576	0.00576	CbGeAlD
Ruxolitinib—TYK2—female reproductive system—fallopian tube cancer	0.00568	0.00568	CbGeAlD
Ruxolitinib—MKNK2—female reproductive system—fallopian tube cancer	0.00561	0.00561	CbGeAlD
Ruxolitinib—IRAK1—female reproductive system—fallopian tube cancer	0.00561	0.00561	CbGeAlD
Ruxolitinib—TAOK3—endometrium—fallopian tube cancer	0.00548	0.00548	CbGeAlD
Ruxolitinib—MAP3K2—female gonad—fallopian tube cancer	0.00531	0.00531	CbGeAlD
Ruxolitinib—MAP3K7—female gonad—fallopian tube cancer	0.00526	0.00526	CbGeAlD
Ruxolitinib—MAP3K7—vagina—fallopian tube cancer	0.00523	0.00523	CbGeAlD
Ruxolitinib—TYK2—female gonad—fallopian tube cancer	0.00517	0.00517	CbGeAlD
Ruxolitinib—JAK2—female reproductive system—fallopian tube cancer	0.00517	0.00517	CbGeAlD
Ruxolitinib—TYK2—vagina—fallopian tube cancer	0.00514	0.00514	CbGeAlD
Ruxolitinib—MKNK2—female gonad—fallopian tube cancer	0.0051	0.0051	CbGeAlD
Ruxolitinib—IRAK1—female gonad—fallopian tube cancer	0.0051	0.0051	CbGeAlD
Ruxolitinib—MKNK2—vagina—fallopian tube cancer	0.00507	0.00507	CbGeAlD
Ruxolitinib—TAOK3—uterus—fallopian tube cancer	0.00505	0.00505	CbGeAlD
Ruxolitinib—MAP3K3—female reproductive system—fallopian tube cancer	0.00498	0.00498	CbGeAlD
Ruxolitinib—JAK2—female gonad—fallopian tube cancer	0.0047	0.0047	CbGeAlD
Ruxolitinib—JAK2—vagina—fallopian tube cancer	0.00467	0.00467	CbGeAlD
Ruxolitinib—TAOK3—female reproductive system—fallopian tube cancer	0.00454	0.00454	CbGeAlD
Ruxolitinib—MAP3K3—female gonad—fallopian tube cancer	0.00453	0.00453	CbGeAlD
Ruxolitinib—MAP3K3—vagina—fallopian tube cancer	0.0045	0.0045	CbGeAlD
Ruxolitinib—TAOK3—female gonad—fallopian tube cancer	0.00413	0.00413	CbGeAlD
Ruxolitinib—TAOK3—vagina—fallopian tube cancer	0.00411	0.00411	CbGeAlD
Ruxolitinib—CYP3A4—female reproductive system—fallopian tube cancer	0.00138	0.00138	CbGeAlD
